首页> 外文期刊>Chromatographia >Development and Validation of a Stability-Indicating LC Method for Simultaneous Analysis of Aceclofenac and Paracetamol in Conventional Tablets and in Microsphere Formulations
【24h】

Development and Validation of a Stability-Indicating LC Method for Simultaneous Analysis of Aceclofenac and Paracetamol in Conventional Tablets and in Microsphere Formulations

机译:同时分析传统片剂和微球制剂中醋氯芬酸和扑热息痛的稳定性指示LC方法的开发和验证

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A stability-indicating reversed-phase LC method for analysis of aceclofenac and paracetamol in tablets and in microsphere formulations has been developed and validated. The mobile phase was 80:20 (v/v) methanol–phosphate buffer (10 mM at pH 2.5 ± 0.02). UV detection was at 276 nm. The method was linear over the concentration ranges 16–24 and 80–120 μg mL−1 for aceclofenac and paracetamol, respectively, with recovery in the range 100.9–102.22%. The limits of detection and quantitation for ACF were 0.0369 and 0.1120 μg mL−1, respectively; those for PCM were 0.0631 and 0.1911 μg mL−1, respectively.
机译:已经开发并验证了用于指示片剂和微球制剂中醋氯芬酸和扑热息痛的稳定性指示反相液相色谱方法。流动相为80:20(v / v)的甲醇-磷酸盐缓冲液(pH 2.5±0.02时为10 mM)。 UV检测在276nm处。该方法在醋氯芬酸和扑热息痛的浓度范围分别为16–24和80–120μgmL -1 时呈线性,回收率在100.9–102.22%之间。 ACF的检出限和定量限分别为0.0369和0.1120μgmL -1 ; PCM的分别为0.0631和0.1911μgmL -1

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号